Role of Oxaliplatin in the Neoadjuvant Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: a Review of Evidence

Role of Oxaliplatin in the Neoadjuvant Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: a Review of Evidence

The treatment of locally advanced rectal cancer (LARC) is a challenging situation for radiation oncologists and colorectal surgeons. Most current approaches recommend neoadjuvant fluorouracil or capecitabine-based chemoradiotherapy followed by surgery as a standard of care. Intensification of concur...

Full description

Bibliographic Details
Main Authors:	Reza Nazari, Guglielmo Niccolò Piozzi, Reza Ghalehtaki, Seyed Mohsen Ahmadi-Tafti, Behnam Behboudi, Nima Mousavi Darzikolaee, Mahdi Aghili, Maria Antonietta Gambacorta
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-03-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	https://doi.org/10.1177/11795549241236409

Similar Items

Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis
by: Amirali Azimi, et al.
Published: (2024-12-01)

The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
by: Parmida Sadat Pezeshki, et al.
Published: (2023-09-01)

Optimal Sequence for Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: An Evidence‐Based Review
by: Reza Ghalehtaki, et al.
Published: (2024-10-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
by: Hsin-Hua Lee, et al.
Published: (2022-05-01)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)

Complication and response assessment of high-dose-rate endorectal brachytherapy boost in neo-adjuvant chemoradiotherapy of locally advanced rectal cancer with long-term outcomes
by: Arefeh Saeedian, et al.
Published: (2023-04-01)

Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study
by: Jiaqi He, et al.
Published: (2024-10-01)

Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy
by: Yi Sun, et al.
Published: (2023-03-01)

Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01)

Prognostic value of pseudotime from texture parameters of FDG PET/CT in locally advanced rectal cancer with neoadjuvant concurrent chemoradiotherapy
by: Hyunjong Lee, et al.
Published: (2024-12-01)

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Hanyang Wang, et al.
Published: (2022-08-01)

Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
by: Hsu Yu-Jen, et al.
Published: (2022-09-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before surgery in patients with locally advanced rectal cancer
by: Aly Mohammed Azmy, et al.
Published: (2022-01-01)

Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer
by: Yue Teng, et al.
Published: (2024-01-01)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?
by: Fokas, E, et al.
Published: (2015)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon?
by: Fokas, E, et al.
Published: (2015)

Hemoglobin Level as a Prognostic Factor of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer
by: Berrin Yalçın, et al.
Published: (2024-11-01)

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01)

Clinical influence of neoadjuvant chemoradiotherapy on immunonutritional status in locally advanced rectal cancer
by: Soohyeon Lee, et al.
Published: (2023-06-01)

Review and prospect of neoadjuvant chemoradiotherapy combined with immunotherapy in locally advanced rectal cancer
by: WANG Yaqi, XIA Fan, ZHANG Zhen
Published: (2024-05-01)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
by: Liwen Qian, et al.
Published: (2022-05-01)

Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer
by: Mary Smithson, et al.
Published: (2022-03-01)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
by: Jung Kyong Shin, et al.
Published: (2022-05-01)

Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients
by: Hua Yang, et al.
Published: (2024-05-01)

Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer
by: Lucian Dragoș Bratu, et al.
Published: (2024-04-01)

MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
by: Franklin, J, et al.
Published: (2012)

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
by: Lafarge, MW, et al.
Published: (2024)

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
by: Xiangwen Tan, et al.
Published: (2024-08-01)

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
by: Maxime W. Lafarge, et al.
Published: (2024-04-01)

Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Shoji Miyako, et al.
Published: (2023-01-01)

Laparoscopic total pelvic exenteration after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Chu-Ying Wu, et al.
Published: (2022-11-01)

The role of MRI with diffusion-weighted imaging in restaging rectal cancers after neoadjuvant chemoradiotherapy
by: Irem Bayram, et al.
Published: (2016-09-01)

Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
by: Yiyi Zhang, et al.
Published: (2020-09-01)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
by: Fang He, et al.
Published: (2022-10-01)